| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14728222.7.5.613 |
| P953 | full work available at URL | http://www.tandfonline.com/doi/pdf/10.1517/14728222.7.5.613 |
| P698 | PubMed publication ID | 14498824 |
| P5875 | ResearchGate publication ID | 9089347 |
| P50 | author | Olaf Stüve | Q30353210 |
| Lawrence Steinman | Q57003134 | ||
| P2093 | author name string | Sawsan Youssef | |
| Anthony Slavin | |||
| Shannon Dunn | |||
| Thomas Prod'homme | |||
| Scott S. Zamvil | |||
| P2860 | cites work | Drug Metabolism and Disposition | Q1261140 |
| Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages | Q24561388 | ||
| Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain | Q27619685 | ||
| Structural mechanism for statin inhibition of HMG-CoA reductase | Q27631717 | ||
| Ciba Foundation Symposium | Q27710394 | ||
| The immunological synapse: a molecular machine controlling T cell activation | Q28139151 | ||
| A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22 | Q28283861 | ||
| Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis | Q28285576 | ||
| Posttranslational modification of proteins by isoprenoids in mammalian cells | Q28303329 | ||
| Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions | Q28366501 | ||
| Rho GTPases and signaling networks | Q28646215 | ||
| Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm | Q29547181 | ||
| Functional diversity of helper T lymphocytes | Q29619415 | ||
| Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis | Q33180102 | ||
| An overview of the clinical safety profile of atorvastatin (lipitor), a new HMG-CoA reductase inhibitor | Q33487463 | ||
| Adhesion molecule expression and regulation on cells of the central nervous system | Q33701566 | ||
| New insights into the pharmacodynamic and pharmacokinetic properties of statins. | Q33832848 | ||
| Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. | Q33886675 | ||
| HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course | Q33904555 | ||
| Non-lipid-related effects of statins | Q33924588 | ||
| Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis | Q73009755 | ||
| Statins as a newly recognized type of immunomodulator | Q73252634 | ||
| Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials | Q73304754 | ||
| Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]) | Q73606171 | ||
| Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9 | Q73979408 | ||
| Inhibition of monocyte chemotactic protein-1 synthesis by statins | Q74045131 | ||
| Multiple sclerosis: a two-stage disease | Q74433993 | ||
| Induction of macrophage-derived chemokine/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation | Q74775333 | ||
| HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages | Q77544869 | ||
| Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1 | Q77900081 | ||
| The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment | Q77920238 | ||
| Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin | Q78076743 | ||
| Statins and risk of polyneuropathy: a case-control study | Q33959147 | ||
| NF-kappaB activation and IkappaB alpha dynamism involved in iNOS and chemokine induction in astroglial cells | Q34196441 | ||
| Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust | Q34196622 | ||
| Statins as potential therapeutic agents in neuroinflammatory disorders | Q34213875 | ||
| Metalloproteinases in biology and pathology of the nervous system. | Q34297141 | ||
| Regulation of MHC class II genes: lessons from a disease | Q34389691 | ||
| Myopathy and rhabdomyolysis with lipid-lowering drugs | Q34547156 | ||
| Revised estimate of the prevalence of multiple sclerosis in the united states | Q34563612 | ||
| Isoprenoids as mediators of the biological effects of statins | Q34774535 | ||
| Characterization of chemokines and their receptors in the central nervous system: physiopathological implications | Q34920888 | ||
| Statins as anti-inflammatory agents | Q34942903 | ||
| Immunological aspects of demyelinating diseases | Q35319665 | ||
| Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin | Q36370581 | ||
| Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation | Q36476893 | ||
| Prenyl proteins in eukaryotic cells: a new type of membrane anchor | Q37923158 | ||
| The T lymphocyte in experimental allergic encephalomyelitis | Q37925549 | ||
| Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species | Q40401707 | ||
| Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration | Q40543299 | ||
| Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 | ||
| Epidemiology of multiple sclerosis: a critical overview. | Q40894258 | ||
| Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. | Q40956460 | ||
| Effects of statins on triglyceride metabolism | Q41731947 | ||
| Class II transactivator regulates the expression of multiple genes involved in antigen presentation | Q41944761 | ||
| Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis | Q42177739 | ||
| Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells. | Q43640125 | ||
| Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis | Q43760330 | ||
| Cerivastatin and reports of fatal rhabdomyolysis | Q43886363 | ||
| Statins as immunomodulators: comparison with interferon-beta 1b in MS. | Q44172256 | ||
| CD2-mediated adhesion facilitates T lymphocyte antigen recognition function | Q44684718 | ||
| Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. | Q48409288 | ||
| A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility | Q48599347 | ||
| Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. | Q48841710 | ||
| Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. | Q52126480 | ||
| Sex differences in autoimmune disease | Q55970264 | ||
| Costimulation: building an immunological synapse | Q57962343 | ||
| Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, | Q67543574 | ||
| T-lymphocyte entry into the central nervous system | Q70156307 | ||
| Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome | Q70529706 | ||
| The adhesion molecule and cytokine profile of multiple sclerosis lesions | Q71688111 | ||
| Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation | Q71710419 | ||
| Relevance of experimental allergic encephalomyelitis to multiple sclerosis | Q72751257 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| molecular medicine | Q3523816 | ||
| pharmacology | Q128406 | ||
| P304 | page(s) | 613-622 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | Statins and their potential targets in multiple sclerosis therapy | |
| P478 | volume | 7 |
| Q49090389 | Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy |
| Q89620715 | Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy |
| Q35891544 | Combination therapy for multiple sclerosis: the treatment strategy of the future? |
| Q37091141 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures |
| Q37543452 | Inhibition of interferon-beta responses in multiple sclerosis immune cells associated with high-dose statins |
| Q28388335 | Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases |
| Q35830997 | Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. |
| Q48086898 | Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial |
| Q24684244 | The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins |
| Q27009126 | The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis |
Search more.